Navigate Compliance, Accelerate Approvals
At Indivirtus, our regulatory strategy and regulatory compliance consulting services are your blueprint for success. We help pharmaceutical and biotech innovators navigate the intricate global regulatory landscape. From early-stage planning to post-marketing support, we design tailored strategies that ensure compliance and accelerate your path to market with agencies like the FDA, EMA, and beyond.
Think of it as your product's master plan for global approval. Our regulatory affairs services cover everything from gap assessments and pathway analysis to agency meeting prep and strategies for faster approvals, ensuring you're ready for every milestone.
A solid regulatory strategy is the difference between a smooth launch and costly delays. It ensures you meet global standards, avoid common pitfalls, and leverage every opportunity for expedited review, ultimately fast-tracking your market access.
As your trusted CRO partner, Indivirtus provides expert-led regulatory consulting. We give you the strategic clarity needed to navigate complex requirements and achieve your submission goals with confidence.
Our approach to regulatory strategy is hands-on and expert-led. Our certified professionals bring years of global compliance experience to the table. We begin by deeply understanding your product and goals, then conduct thorough gap assessments, build a global pathway roadmap, manage your agency meetings, and identify opportunities for expedited programs.
This bespoke process ensures you have a clear, efficient path forward, fully aligned with ICH, FDA, and EMA guidelines.
Global Regulatory Pathway Roadmap: A comprehensive, easy-to-follow plan for your global submissions.
Agency Meeting Briefing Documents: Professionally prepared materials for your consultations with the FDA, EMA, and other bodies.
Gap Analysis & Regulatory Reports: A detailed assessment with actionable recommendations to address any compliance gaps.
Expedited Program Strategy: A tailored plan to help you qualify for fast-track approval programs.
We anchor our regulatory compliance consulting in the world's most stringent standards. This ensures your submissions aren't just compliant, but optimized for success in international markets. By building our strategies on industry-leading guidelines, we give you the confidence that comes from a well-prepared and defensible regulatory plan.
Our regulatory affairs services are essential for any pharmaceutical or biotech company navigating the global regulatory maze. We're an ideal partner for firms in early-stage planning, those seeking expedited approvals, or those preparing for global submissions. We help develop winning strategies for new drug applications, manage critical agency consultations, and optimize your eligibility for programs that can speed up your timeline.
Indivirtus is a trusted partner for pharmaceutical and biotech companies because we deliver expert-led regulatory strategy solutions. Our certified professionals have extensive global experience, ensuring scientifically sound outcomes, rapid delivery, and the strictest confidentiality.
We empower your organization with compliant, strategic, and forward-thinking regulatory plans that drive approval success and market readiness.
It's our strategic process for mapping out the most efficient submission routes for your product across the globe. We analyze regional requirements, your product's classification, and your target markets to create a clear, customized roadmap.
These consultations are crucial for aligning your development plan with what regulators expect to see. Getting their feedback early helps prevent major delays or rejections down the line, saving you time and resources.
We provide strategic support for a variety of programs, including the FDA's Fast Track, Breakthrough Therapy, and Accelerated Approval, as well as the EMA’s PRIME scheme, based on your product's eligibility.
We perform a deep dive into your current regulatory and technical documentation, comparing it against international standards. We then provide clear regulatory reports detailing any gaps and a roadmap for becoming submission-ready.
Yes, absolutely. Our regulatory consulting is customized for companies of all sizes. We provide foundational guidance for early-stage startups to ensure you start on the right compliance path from day one.
Yes, every strategy we create is fully customized. Our services are tailored to your unique drug product, specific regulatory goals, and target markets to ensure a compliant and effective plan.